JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist
  • 46
  • +2+4.55%
20min DelayMarket Closed Dec 27 15:30 JST
3.99BMarket Cap-2.53P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BrightPath Biotherapeutics Q2 2025 Earnings Date

Currency：JPYNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
EPS
--
-2.45
--
+40.41%
NI to Common Holders
--
-208.00M
--
+19.43%
Analyst Rating
No Data

BrightPath Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

No Data

BrightPath Biotherapeutics Earnings Reports

  • BrightPath Biotherapeutics: Confirmation letter

    Nov 8 01:35 ET

  • BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)

    Nov 8 01:34 ET

  • BrightPath Biotherapeutics: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

    Nov 8 01:30 ET

  • BrightPath Biotherapeutics: 1Q financial results briefing for March 2025 [Japan standard] (non-consolidated).

    Aug 9 02:00 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Twenty-four seven
    7074
    290 +33.64%
    Alpico Holdings
    297A
    321 +33.20%
    Branding Technology
    7067
    1338 +28.90%
    Estore
    4304
    1504 +24.92%
    Axel Mark
    3624
    172 +22.86%

    See the daily top gainer.